PDUFA Date for Aficamten in Obstructive HCM Extended by FDA to December 26, 2025
Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update
Seeking Alpha / 27 minutes ago 1 Views
Seeking Alpha / 27 minutes ago 1 Views
PDUFA Date for Aficamten in Obstructive HCM Extended by FDA to December 26, 2025
Comments